Intra-Cellular Therapies ... (ITCI)
NASDAQ: ITCI
· Real-Time Price · USD
131.87
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM
Grant Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 112K | -104K | -48.15% |
| Sep 30, 2024 | 216K | 104K | +92.86% |
| Jun 30, 2024 | 112K | 89K | +386.96% |
| Mar 31, 2024 | 23K | -570K | -96.12% |
| Dec 31, 2023 | 593K | 230K | +63.36% |
| Sep 30, 2023 | 363K | -301K | -45.33% |
| Jun 30, 2023 | 664K | -94.07M | -99.30% |
| Mar 31, 2023 | 94.73M | 7.3M | +8.35% |
| Dec 31, 2022 | 87.43M | 15.56M | +21.65% |
| Sep 30, 2022 | 71.87M | 16.8M | +30.50% |
| Jun 30, 2022 | 55.07M | 20.32M | +58.46% |
| Mar 31, 2022 | 34.76M | 9.24M | +36.21% |
| Dec 31, 2021 | 25.52M | 3.91M | +18.10% |
| Sep 30, 2021 | 21.61M | 2.6M | +13.68% |
| Jun 30, 2021 | 19.01M | 3.43M | +22.00% |
| Mar 31, 2021 | 15.58M | 15.53M | +30739.55% |
| Dec 31, 2020 | 50.52K | 50.52K | n/a |
| Sep 30, 2020 | 0 | -30.75K | -100.00% |
| Jun 30, 2020 | 30.75K | -170.22K | -84.70% |
| Mar 31, 2020 | 200.96K | n/a | n/a |